Day: July 26, 2024

At the initiative and by the decision of the Board of AUGA group, AB (code 126264360, address Konstitucijos ave. 21C, Vilnius, the Company) the extraordinary general meeting of shareholders of the Company is being convened on 20th August 2024, at 10.00 a.m. The meeting will be held in the registered office of the Company, address Konstitucijos ave. 21C,  Quadrum North 12 floor, LT-08130 Vilnius, Lithuania. The registration of the shareholders begins at 9:30 a.m. Only those persons who will be shareholders of the Company at the close of the record date of the general meeting of shareholders may participate and vote at the general meeting of shareholders. The record date of the meeting shall be 12th August 2024. Agenda of the Meeting:Appointment of the auditor to audit consolidated financial statements of the Company for the year 2024...

NEW ALBANY, Ohio, July 26, 2024 (GLOBE NEWSWIRE) — CVG (NASDAQ: CVGI) will hold its quarterly conference call on Tuesday, August 6, 2024, at 8:30 a.m. ET, to discuss second quarter 2024 financial results. CVG will issue a press release and presentation prior to the conference call. Toll-free participants dial (800) 549-8228 using conference code 11335. International participants dial (289) 819-1520 using conference code 11335. This call is being webcast and can be accessed through the “Investors” section of CVG’s website at ir.cvgrp.com where it will be archived for one year. A telephonic replay of the conference call will be available until August 20, 2024. To access the replay, toll-free callers can dial (877) 674-7070 using access code 11335#. About CVG At CVG, we deliver real solutions to complex design, engineering and manufacturing...

ATHENS, Greece, July 26, 2024 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced the successful signing of a US$167.3 million six-year secured term loan facility with Nordea Bank Abp, filial i Norge on July 25, 2024. The full amount was drawn down immediately. The new loan maturing in July 2030 is secured by ten vessels. The proceeds have been utilized to refinance two of the Company’s existing loan facilities with Nordea Bank Abp, filial i Norge: one for US$149.3 million and the other for US$18.0 million, originally maturing in October 2027 and June 2028, respectively. These loans were previously secured by twelve vessels. As part of this refinancing, two of the Company’s mortgaged vessels have...

Press release Paris, 26 July 2024 Publication of Orange’s 2024 interim financial report Orange announces the publication of its first half 2024 financial report. The report was filed with the French Financial Markets Authority (AMF) and submitted to the U.S. Securities and Exchange Commission, and is available on the website of the Company at the following address: https://www.orange.com/en/regulated-information About Orange Orange is one of the world’s leading telecommunications operators with revenues of 39.7 billion euros in 2023 and 128,000 employees worldwide at 30 June 2024, including 72,000 employees in France. The Group has a total customer base of 285 million customers worldwide at 30 June 2024, including 246 million mobile customers and 21 million fixed broadband customers. These figures have been restated to account for...

MINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, today announced that the first patient has been treated with the newly launched QUELIMMUNE™ therapy in a commercial setting at Cincinnati Children’s. QUELIMMUNE, manufactured for SeaStar Medical (Nasdaq: ICU) and exclusively licensed and distributed in U.S. pediatric hospitals by Nuwellis, is a novel therapy designed to treat pediatric patients (weighing 10 kg or more) suffering from acute kidney injury (AKI) with sepsis or a septic condition and requiring kidney replacement therapy (KRT). Dr. Stuart Goldstein, Director of the Center for Acute Care Nephrology at Cincinnati Children’s, and Principal Investigator of the multi-center studies...

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced an analysis published by the Innovation Value Institute (IVI) titled “Introduction of AI assisted Digital Health Technology to Improve Cardiovascular Pathway Efficiency” focused on the MyoVista® wavECG™’s potential to radically improve the cardiovascular pathway efficiency. Founded in 2006, the Maynooth University, Ireland based IVI is a multidisciplinary research institute focused on digital transformation and technology adoption.  The paper analyzed the potential impact of using the MyoVista wavECG...

BEN’s AI technology, paired with Vybroo’s vast radio and audio network, will boost brands’ reputations with listeners by offering suggestions and highlighting opportunities JACKSON, Wyo., July 26, 2024 (GLOBE NEWSWIRE) — Brand Engagement Network (BEN), (Nasdaq: BNAI), an emerging provider of safe, personalized customer engagement AI, Vybroo, a company that connects brands with customers through innovative audio messaging strategies, and Farmacia Roma, a pharmacy chain based in Baja California, today announced a commercial agreement that will pair BEN’s and Vybroo’s unique brand-to-customer communication strategies and technologies, including BEN’s cutting-edge human-modeled AI assistants, to vastly improve customer experiences and brand engagement opportunities. Together, the companies are collaborating to merge BEN’s proprietary...

CHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) — NN, Inc. (NASDAQ: NNBR), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, announced today that it will release its second quarter 2024 financial results for the period ended June 30, 2024, after the close of the market on Wednesday, August 7, 2024. The company will hold a related conference call on Thursday, August 8, 2024, at 10 a.m. E.T. Participants on the call are asked to register five to 10 minutes prior to the scheduled start time by dialing 1-877-255-4315 and from outside the U.S. at 1-412-317-6579. The conference call will be webcast simultaneously and in its entirety through the NN, Inc. Investor Relations website. Shareholders, media representatives and others may participate in the webcast by registering...

Rumble is now available on Xbox, giving users more ways to consume a wide range of content. LONGBOAT KEY, Fla., July 26, 2024 (GLOBE NEWSWIRE) — Rumble, the video-sharing platform and cloud services provider (NASDAQ: RUM), announced today the release of its new Xbox app, which allows users to stream live and on-demand content from creators 24/7. Users can download the Rumble app on their Xbox devices for access to a variety of video content, including gaming creators, exclusive podcasts, live sports, top political pundits, cute pets, and more. In addition to the availability of Rumble on Apple TV, Roku, Amazon Fire TV, LG Smart TVs, and Samsung TV apps, the Xbox app provides users another option for watching videos on their televisions. Chris Pavlovski, Founder and Chief Executive Officer of Rumble, commented, “The launch of the...

Boston (July 26, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, announced that its Board of Directors has decided to postpone the Annual Meeting of Stockholders, which was originally scheduled for 10:00 AM Eastern Time today, July 26, 2024. On July 25, 2024, the Board, exercising its authority under the Company’s bylaws, opted to delay the meeting to a future date, which will be determined and announced in due course. The Company will provide updated information regarding the new date for the Annual Meeting and, if necessary, a new record date, as soon as it becomes available. About Allarity TherapeuticsAllarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage biopharmaceutical company dedicated...